PROTID is a network of scientists and clinicians from institutes in the Netherlands, Uganda, Tanzania, United Kingdom and New Zealand. The consortium partners share an ambition to prevent TB among people with diabetes.
The project is coordinated by Radboudumc from Nijmegen, The Netherlands. Partner NIMR MMRC in Mbeya, Tanzania is sponsor of the trial.
PROTID’s Scientific Advisory Board (SAB) consists of five independent scientists who together act as an advisory capacity to review results and research plans, to provide the Executive Group with recommendations on the continuation and to safeguard the interest of the project.
Read more
The Radboud university medical center (Radboudumc) is the Coordinator of the PROTID project and responsible for project management, capacity development and training, stakeholder engagement and dissemination.
Read more
Uganda Martyrs Hospital Lubaga will be one of the main recruiting sites in Uganda.
Read more
KCMC is leading the Work Package on preventive and therapeutic management of combined diabetes mellitus and TB
Read more
St George’s University is leading the economic evaluation Work Package.
Read more
King’s Health Economics is working closely with SGUL on the economic evaluation Work Package.
Read more
NIMR-MMRC is the main lead for the trial management and sponsor of the multicenter randomized clinical trial on preventive treatment and the parallel prospective cohort study.
Read more
